Skip to main content

Find Clinical Trials

Home
Conditions
BRAF NP_004324.2:p.V600X

Clinical trial condition

BRAF NP_004324.2:p.V600X

Explore clinical trials studying BRAF NP_004324.2:p.V600X. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

BRAF NP_004324.2:p.V600X trial results

Completed

Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

NCT01787500

Conditions: BRAF NP_004324.2:p.V600X, Colonic Diseases, Colorectal Neoplasms, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details